Are you Dr. Charrow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
225 E Chicago Ave
Chicago, IL 60611Phone+1 312-227-6120Fax+1 312-227-9413- Is this information wrong?
Summary
- Dr. Joel Charrow, MD is a board certified medical geneticist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern Memorial Hospital.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1976 - 1981
- Icahn School of Medicine at Mount SinaiClass of 1976
Certifications & Licensure
- IL State Medical License 1977 - 2026
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Open-Label Phase 3 Long-Term Safety Study of Migalastat Start of enrollment: 2011 Oct 14
- Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease Start of enrollment: 2015 Mar 14
Publications & Presentations
PubMed
- Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.Jeremy Lorber, Claus Niederau, Jenny L Carwile, Antonio Oliveira-Dos-Santos, Maria Gabriela Perichon, Sefika Uslu Cil, Pramod K Mistry, Manisha Balwani, Joel Charrow, ...> ;American Journal of Hematology. 2024 Apr 30
- 2 citationsVosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.Ravi Savarirayan, William R Wilcox, Paul Harmatz, John Phillips 3rd, Lynda E Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A Bacino, Donal...> ;The Lancet. Child & Adolescent Health. 2024 Jan 1
- 1 citationsTreatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease.Carly A Rasmussen, Allegra Quadri, Erika Vucko, Katherine Kim, Rachel Hickey, Joshua J Baker, Joel Charrow, Carlos E Prada> ;Molecular Genetics and Metabolism. 2024 Jan 1
- Join now to see all
Press Mentions
- Children with Achondroplasia Could Increase Bone Growth with Novel DrugOctober 27th, 2020
- Experimental Drug Can Encourage Bone Growth in Children with DwarfismJune 18th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
- Northwestern Memorial HospitalChicago, Illinois
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois